E
Neumora Therapeutics, Inc. NMRA
$1.28 -$0.12-8.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 51.39% 4.93% 63.50% 47.86% 56.16%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 25.59% 34.79% 51.73% 53.38% 63.10%
Operating Income -25.59% -34.79% -51.73% -53.38% -63.10%
Income Before Tax 45.77% -36.71% -51.97% -50.80% -285.35%
Income Tax Expenses -100.00% -- -- -- --
Earnings from Continuing Operations 45.90% -36.81% -52.30% -50.80% -286.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 45.90% -36.81% -52.30% -50.80% -286.31%
EBIT -25.59% -34.79% -51.73% -53.38% -63.10%
EBITDA -25.70% -34.92% -51.97% -53.59% -63.34%
EPS Basic 48.64% 59.97% 71.14% 72.05% 28.46%
Normalized Basic EPS -25.36% 60.00% 71.20% 72.04% 70.70%
EPS Diluted 48.64% 59.97% 71.14% 72.05% 28.46%
Normalized Diluted EPS -25.36% 60.00% 71.20% 72.04% 70.70%
Average Basic Shares Outstanding 5.33% 241.77% 427.75% 439.48% 439.95%
Average Diluted Shares Outstanding 5.33% 241.77% 427.75% 439.48% 439.95%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings